Compounds > glutamine

glutamine and Daytime Sleepiness

glutamine has been researched along with Daytime Sleepiness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ames, MM; Buckner, JC; Cascino, TL; Figg, WD; Lim, S; Malkin, MG; Reed, E; Reid, JM; Tong, WP1
Bowling, MK; Carducci, MA; Chen, TL; Donehower, RC; Eisenberger, MA; Gilbert, J; Grochow, LB; Noe, D; Sinibaldi, V; Zabelina, Y1

Trials

2 trial(s) available for glutamine and Daytime Sleepiness

ArticleYear
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:2

    Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Confusion; Disorders of Excessive Somnolence; Drug Administration Schedule; Drug Combinations; Female; Glioblastoma; Glutamine; Humans; Injections, Intravenous; Male; Middle Aged; Patient Selection; Phenylacetates; Piperidones; Seizures; Severity of Illness Index; Treatment Outcome

1999
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

    Topics: Adult; Antineoplastic Agents; Chromatography, High Pressure Liquid; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Fatigue; Female; Glutamine; Humans; Hypokalemia; Infusions, Intravenous; Male; Metabolic Clearance Rate; Nausea; Neoplasms; Neutropenia; Patient Dropouts; Phenylacetates; Phenylbutyrates; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Tumor Cells, Cultured; Uric Acid

2001